Factors influencing contraceptive implant discontinuation among women receiving implant services from community healthcare providers (CPs/PPMVs) in Nigeria: An analysis of routine service delivery data

Contraceptive implants are among the most effective long-acting reversible contraceptives (LARCs), yet early discontinuation remains a major challenge globally and in Nigeria, undermining family planning (FP) goals. Community Pharmacists (CPs) and Patent and Proprietary Medicine Vendors (PPMVs) have been trained through the IntegratE Project to expand access to implant services, but little evidence exists on discontinuation patterns among their clients. The dataset includes 874 routine service delivery records of women aged 15–49 years who sought implant removal services from trained CPs and Tier 2/3 PPMVs between July 2023 and June 2025 across four Nigerian states (Enugu, Kaduna, Kano, and Lagos). Early discontinuation was defined as removal within two years of insertion. Descriptive statistics summarized socio-demographic and service-related characteristics, while bivariate and multivariate logistic regression identified predictors of early removal. Overall, study findings highlight the importance of tailored interventions to maximize the contribution of community-based providers in advancing Nigeria’s FP goals.